Adipocell™, adipose-derived stem cells for chronic ischemic cardiomyopathy

Adipocell™ are autologous adipose-derived stem cells indicated for the treatment of chronic ischemic cardiomyopathy. Treated patients display a mean 13% improvement in ejection fraction and a mean increase of 100 meters in their 6-minute walk distance. In addition, the majority of patients walk more than 65 meters further at 3 months post-treatment. The patients also report an improvement in life quality. There is an average improvement in exercise capacity or a six minute walk test of approximately 68 meters and an average absolute improvement of 10% points. Five years following treatment all patients report being well compared to their prognosis which is 50% death in untreated patients.